Oral dose for COVID from Indian Drug maker soon

It was very positive. HAL’s performance was reviewed, and future plans were also discussed.

63
Medicine Tablet
Picture: Pixabay

Last Updated on July 6, 2021 by The Health Master

India’s first pharma PSU aims to manufacture medication for mild cases in next 3 months, reinvent its flagging status. India’s first public sector pharmaceutical companyHindustan Antibiotics Ltd (HAL), is ready to perform its role in the pandemic.

The Pimpri-based drug manufacturing unit, set up in 1954, will produce oral medication to tackle mild COVID-19 cases in the next three months. The ailing public sector undertaking (PSU) says it is on the road to recovery and started two new plants on Friday.

HAL managing director Neerja Saraf said, “The decision to manufacture oral medication to tackle mild COVID-19 cases was taken in the HAL review board meeting, held in the plant with Union minister of state for ports, shipping and waterways, and chemicals and fertilisers, Mansukh Mandaviya, on Friday.”

Medicine Factory
Picture: Pixabay

Mandaviya also inaugurated a state-of the-art facility to manufacture alcoholic hand disinfectant and dry powder injectable during his visit. HAL is the only public sector enterprise with this facility in India.

Briefing about the board meeting, Saraf added, “It was very positive. HAL’s performance was reviewed, and future plans were also discussed. Our turnover target for the next financial year is Rs 200 crore.”

Commenting on the manufacturing of the injectable COVID-19 vaccine, Saraf added, “We are exploring the possibility of manufacturing an injectable COVID vaccine, but there is little hope as the HAL plant has an old set-up — for manufacturing, we will need an entirely new one.”

Zydus Cadila gets USFDA nod for drug to treat HIV infection

Alembic gets USFDA nod for Nitrofurantoin Capsules USP

Axio Biosolution gets USFDA nod for Patch for bleeding control

Glenmark gets USFDA nod for generic Lung cancer drug

USFDA okays Tocilizumab for treatment of Covid-19

Zydus Cadila gets tentative nod from USFDA for Pemetrexed for Injection


But on a more optimistic note, MP Manoj Kotak, president of HAL’s union — Hindustan Antibiotics Mazdoor Sangh — who was also present for the meeting, said, “The Union government is positive about manufacturing the COVID-19 injectable vaccine. It is willing to upgrade the HAL plant set-up for the same, with new machinery for production. We have asked the HAL management to send a detailed proposal of the equipment required to manufacture this vaccine and present it to the Union ministry.”

Kotak said that the issues of HAL workers were discussed in the meeting as the arrears are still pending.

Meanwhile, Bhosari Member of Legislative Assembly (MLA) Mahesh Landge met with the ministry officials and submitted a letter to undertake initiatives to start vaccine production for public betterment.

Landge said, “The Pimpri-Chinchwad Municipal Corporation (PCMC) general body meeting unanimously approved of the proposal to provide Rs 25 crore in financial assistance for setting up production of the COVID-19 vaccine. We have demanded that workers be given their arrears as early as possible, and also that the age-old HA Colony located opposite the plant be repaired soon, as it is in a pathetic condition.”

Procedure to obtain License to Manufacture drugs for testing and analysis…

NPPA exempts Torrent Pharma’s this drug from price regulation

Both doses of vaccine provide this much of protection from death:…

Germany recommends mixing of these vaccines

Neurological disorder: Treat Kids without delay: Doctors

Zydus Cadila gets USFDA nod for drug to treat HIV infection

Telegram
WhatsApp
Facebook
LinkedIn
Google-news

Enter your email address:

Delivered by FeedBurner